Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
Hendrik Setia Budi, Firdaus Nuri Ahmad, Harun Achmad, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 113
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target
Selma Ahcene Djaballah, Francesca Daniel, A. Milani, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 219-232
Open Access | Times Cited: 72
Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy
Preeti Dabas, Adithi Danda
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 23
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment
Dasom Kong, Daekee Kwon, BoKyung Moon, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116436-116436
Open Access | Times Cited: 8
NK Cell-Based Immunotherapy in Colorectal Cancer
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 26
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 24
Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor Efficacy
Wenjiao Xia, Jiaxin Chen, Wenqing Hou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6843-6843
Open Access | Times Cited: 16
CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens
John Maher, David M. Davies
Biology (2023) Vol. 12, Iss. 2, pp. 287-287
Open Access | Times Cited: 14
Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer
Yu Cao, Sergey Efetov, Mingze He, et al.
Archivum Immunologiae et Therapiae Experimentalis (2023) Vol. 71, Iss. 1
Closed Access | Times Cited: 14
Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments
Xudong Li, Wei Li, Linping Xu, et al.
Chinese Medical Journal (2023) Vol. 137, Iss. 11, pp. 1285-1302
Open Access | Times Cited: 14
Targeting apoptosis in clear cell renal cell carcinoma
Adam Kowalewski, Jędrzej Borowczak, Mateusz Maniewski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116805-116805
Open Access | Times Cited: 5
Immunotherapies against HER2-Positive Breast Cancer
Santiago Duro‐Sánchez, Macarena Román Alonso, Joaquı́n Arribas
Cancers (2023) Vol. 15, Iss. 4, pp. 1069-1069
Open Access | Times Cited: 12
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 12
Rare Adverse Events of CAR T-Cell Therapy
A Müller, Federico Simonetta
healthbook TIMES Oncology Hematology (2024), Iss. 19
Open Access | Times Cited: 4
Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report
Jianxin Chen, Jian Wang, Qinhong Zheng
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors
Liaoliao Zhu, Jingyi Liu, Junqiang Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang, Yuepeng Cao, Chengshuai Si, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5160-5160
Open Access | Times Cited: 15
The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions
Saleh Alrhmoun, С. В. Сенников
Cancers (2022) Vol. 14, Iss. 24, pp. 6173-6173
Open Access | Times Cited: 15
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells
Guangyu Zhou, Shengyu Fu, Yunsen Zhang, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 45-45
Open Access | Times Cited: 3
Structure-Based Multi-Targeted Molecular Docking and Dynamic Simulation of Soybean-Derived Isoflavone Genistin as a Potential Breast Cancer Signaling Proteins Inhibitor
Abd Elmoneim O. Elkhalifa, Eyad Al-Shammari, Mohammed Kuddus, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1739-1739
Open Access | Times Cited: 8
Exploring the potential of fluoro‐flavonoid derivatives as anti‐lung cancer agents: DFT, molecular docking, and molecular dynamics techniques
Nusrat Jahan Ikbal Esha, Syeda Tasnim Quayum, Minhaz Zabin Saif, et al.
International Journal of Quantum Chemistry (2023) Vol. 124, Iss. 1
Closed Access | Times Cited: 7
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer
Laura R. Moffitt, Nazanin Karimnia, Amy Wilson, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 8023-8038
Open Access | Times Cited: 2
Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer
Zhifeng Zhou, Jieyu Li, Jingwen Hong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Breast cancer vaccines; A comprehensive and updated review
Sulieman Ibraheem Shelash Al‐Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154735-154735
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top